GCAC
MDT icon

Guardian Capital Advisors (Canada)’s Medtronic MDT Stock Holding History

Guardian Capital Advisors (Canada)’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,306
Closed -$552K – 175
2023
Q2 		$552K Buy
+6,306
New +$543K 0.06% 116

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Guardian Capital Advisors (Canada)'s MDT Position: Q3 2023 in Review

Guardian Capital Advisors (Canada) sold out of Medtronic (MDT) in Q3 2023, closing a stake of 6,306 shares — an estimated $552K sold.

Guardian Capital Advisors (Canada) first reported a position in MDT in Q2 2023 and held it in 1 quarter. The position peaked at $552K in Q2 2023. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Guardian Capital Advisors (Canada) reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Guardian Capital Advisors (Canada) sold 6,306 Medtronic shares in Q3 2023, an estimated $552K.
  • Guardian Capital Advisors (Canada) first reported a position in Medtronic in Q2 2023 and held it in 1 quarter.
  • Guardian Capital Advisors (Canada)'s Medtronic position peaked at $552K in Q2 2023.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Guardian Capital Advisors (Canada)'s 13F filing for Q3 2023, filed 13 Nov 2023.